Home / Health / Heart Infections Drop: Stimulants Shift Blamed
Heart Infections Drop: Stimulants Shift Blamed
29 Oct
Summary
- Drug-related heart infections declined 18% from 2020 to 2022.
- Stimulant drug use increasingly linked to heart infections.
- Opioid-linked infections decreased, while stimulant cases rose.
A notable decrease in severe heart infections associated with illicit drug use has been observed in the United States. Data from 2022 indicates an 18% reduction in such cases compared to 2020.
However, this decline is accompanied by a shift in the types of drugs involved. While opioid-related infections have decreased, stimulant drugs like methamphetamine are now implicated in a growing number of these heart infections. This marks a significant change from previous years when opioids were the primary driver.
Researchers attribute the overall drop potentially to expanded addiction treatment and harm-reduction services. The increasing prevalence of stimulant-linked infections highlights a need for more effective treatment strategies for stimulant use disorder, as current healthcare tools are less developed for these substances compared to opioids.
The study analyzed federal hospitalization data from 2016 to 2022, identifying a peak in drug-use-associated endocarditis in 2020. The findings suggest a complex interplay between drug use patterns and public health interventions.
